UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
|
|||||||
WASHINGTON,
D.C. 20549
|
|||||||
FORM
8-K
|
|||||||
CURRENT
REPORT
|
|||||||
PURSUANT
TO SECTION 13 OR 15 (d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
|
|||||||
Date
of Report (Date of earliest event reported): December 15,
2009
|
|||||||
GERBER SCIENTIFIC, INC.
(Exact
name of Registrant as specified in its charter)
|
|||||||
CONNECTICUT
|
1-5865
|
06-0640743
|
|||||
(State
or other jurisdiction of incorporation)
|
(Commission
File No.)
|
(I.R.S.
Employer Identification No.)
|
|||||
83 Gerber Road West, South Windsor,
Connecticut
|
06074
|
||||||
(Address
of principal executive offices)
|
(Zip
Code)
|
||||||
Registrant’s
Telephone Number, including area code:
|
(860) 644-1551
|
||||||
Not Applicable
|
|||||||
(Former
name or former address, if changed since last report)
|
|||||||
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
|
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
For
the Fiscal Quarters Ended
|
For
the Six Months Ended
|
|||||||||||
In
thousands except per share data
|
July
31, 2009
|
October
31, 2009
|
October
31, 2009
|
|||||||||
Revenue:
|
||||||||||||
Product
sales
|
$ | 93,764 | $ | 103,546 | $ | 197,310 | ||||||
Service
sales
|
16,824 | 16,614 | 33,438 | |||||||||
110,588 | 120,160 | 230,748 | ||||||||||
Cost
of Sales:
|
||||||||||||
Cost
of products sold
|
68,784 | 74,646 | 143,430 | |||||||||
Cost
of services sold
|
9,777 | 10,294 | 20,071 | |||||||||
78,561 | 84,940 | 163,501 | ||||||||||
Gross
profit
|
32,027 | 35,220 | 67,247 | |||||||||
Selling,
general and administrative expenses
|
24,150 | 27,817 | 51,967 | |||||||||
Research
and development
|
4,428 | 4,532 | 8,960 | |||||||||
Operating
income
|
3,449 | 2,871 | 6,320 | |||||||||
Other
income (expense), net
|
(1,005 | ) | (394 | ) | (1,399 | ) | ||||||
Interest
expense
|
(942 | ) | (918 | ) | (1,860 | ) | ||||||
Income
from continuing operations before
income
taxes
|
1,502 | 1,559 | 3,061 | |||||||||
Income
tax expense (benefit)
|
359 | (374 | ) | (15 | ) | |||||||
Income
from continuing operations
|
1,143 | 1,933 | 3,076 | |||||||||
Loss
from discontinued operations, net of
taxes
|
(629 | ) | (1,474 | ) | (2,103 | ) | ||||||
Net
income
|
$ | 514 | $ | 459 | $ | 973 | ||||||
Basic
earnings (loss) per common share:
|
||||||||||||
Continuing
operations
|
$ | 0.05 | $ | 0.08 | $ | 0.12 | ||||||
Discontinued
operations
|
(0.03 | ) | (0.06 | ) | (0.08 | ) | ||||||
Basic
earnings per common share
|
$ | 0.02 | $ | 0.02 | $ | 0.04 | ||||||
Diluted
earnings (loss) per common share:
|
||||||||||||
Continuing
operations
|
$ | 0.05 | $ | 0.08 | $ | 0.12 | ||||||
Discontinued
operations
|
(0.03 | ) | (0.06 | ) | (0.08 | ) | ||||||
Diluted
earnings per common share
|
$ | 0.02 | $ | 0.02 | $ | 0.04 |
For
the Fiscal Quarters Ended
|
For
the Fiscal Year Ended
|
|||||||||||||||||||
In
thousands except per share data
|
July
31, 2008
|
October
31, 2008
|
January
31, 2009
|
April
30, 2009
|
April
30, 2009
|
|||||||||||||||
Revenue:
|
||||||||||||||||||||
Product
sales
|
$ | 129,190 | $ | 123,760 | $ | 88,752 | $ | 91,664 | $ | 433,366 | ||||||||||
Service
sales
|
18,975 | 18,793 | 17,439 | 16,182 | 71,389 | |||||||||||||||
148,165 | 142,553 | 106,191 | 107,846 | 504,755 | ||||||||||||||||
Cost
of Sales:
|
||||||||||||||||||||
Cost
of products sold
|
94,813 | 88,811 | 63,674 | 67,374 | 314,672 | |||||||||||||||
Cost
of services sold
|
13,008 | 12,337 | 10,291 | 9,738 | 45,374 | |||||||||||||||
107,821 | 101,148 | 73,965 | 77,112 | 360,046 | ||||||||||||||||
Gross
profit
|
40,344 | 41,405 | 32,226 | 30,734 | 144,709 | |||||||||||||||
Selling,
general and administrative expenses
|
32,563 | 30,155 | 27,162 | 26,535 | 116,415 | |||||||||||||||
Research
and development
|
6,233 | 5,698 | 4,847 | 4,345 | 21,123 | |||||||||||||||
Operating
income
|
1,548 | 5,552 | 217 | (146 | ) | 7,171 | ||||||||||||||
Other
income (expense), net
|
(125 | ) | (412 | ) | (2,470 | ) | (64 | ) | (3,071 | ) | ||||||||||
Interest
expense
|
(539 | ) | (748 | ) | (654 | ) | (1,188 | ) | (3,129 | ) | ||||||||||
Income
from continuing operations before
income
taxes
|
884 | 4,392 | (2,907 | ) | (1,398 | ) | 971 | |||||||||||||
Income
tax expense (benefit)
|
160 | (1,973 | ) | (1,616 | ) | (470 | ) | (3,899 | ) | |||||||||||
Income
from continuing operations
|
724 | 6,365 | (1,291 | ) | (928 | ) | 4,870 | |||||||||||||
Loss
from discontinued operations, net of
taxes
|
(43 | ) | (271 | ) | (941 | ) | (1,379 | ) | (2,634 | ) | ||||||||||
Net
income
|
$ | 681 | $ | 6,094 | $ | (2,232 | ) | $ | (2,307 | ) | $ | 2,236 | ||||||||
Basic
earnings (loss) per common share:
|
||||||||||||||||||||
Continuing
operations
|
$ | 0.03 | $ | 0.27 | $ | (0.05 | ) | $ | (0.04 | ) | $ | 0.20 | ||||||||
Discontinued
operations
|
--- | (0.02 | ) | (0.04 | ) | (0.05 | ) | (0.11 | ) | |||||||||||
Basic
earnings (loss) per common share
|
$ | 0.03 | $ | 0.25 | $ | (0.09 | ) | $ | (0.09 | ) | $ | 0.09 | ||||||||
Diluted
earnings (loss) per common share:
|
||||||||||||||||||||
Continuing
operations
|
$ | 0.03 | $ | 0.26 | $ | (0.05 | ) | $ | (0.04 | ) | $ | 0.20 | ||||||||
Discontinued
operations
|
--- | (0.01 | ) | (0.04 | ) | (0.05 | ) | (0.11 | ) | |||||||||||
Diluted
earnings (loss) per common share
|
$ | 0.03 | $ | 0.25 | $ | (0.09 | ) | $ | (0.09 | ) | $ | 0.09 |
For
the Fiscal Quarters Ended
|
For
the Six Months Ended
|
|||||||||||
In
thousands
|
July
31, 2009
|
October
31, 2009
|
October
31, 2009
|
|||||||||
Sign
Making and Specialty Graphics:
|
||||||||||||
Gerber
Scientific Products
|
$ | 10,887 | $ | 13,375 | $ | 24,262 | ||||||
Spandex
|
53,138 | 55,689 | 108,827 | |||||||||
Sign
Making and Specialty Graphics
|
64,025 | 69,064 | 133,089 | |||||||||
Apparel
and Flexible Materials
|
35,060 | 37,094 | 72,154 | |||||||||
Ophthalmic
Lens Processing
|
11,503 | 14,002 | 25,505 | |||||||||
Consolidated
revenue
|
$ | 110,588 | $ | 120,160 | $ | 230,748 | ||||||
Sign
Making and Specialty Graphics:
|
||||||||||||
Gerber
Scientific Products
|
$ | (1,222 | ) | $ | (1,240 | ) | $ | (2,462 | ) | |||
Spandex
|
3,033 | 3,492 | 6,525 | |||||||||
Sign
Making and Specialty Graphics
|
1,811 | 2,252 | 4,063 | |||||||||
Apparel
and Flexible Materials
|
4,159 | 3,298 | 7,457 | |||||||||
Ophthalmic
Lens Processing
|
695 | 1,625 | 2,320 | |||||||||
Segment
operating income
|
6,665 | 7,175 | 13,840 | |||||||||
Corporate
operating expenses
|
(3,216 | ) | (4,304 | ) | (7,520 | ) | ||||||
Consolidated operating
income
|
$ | 3,449 | $ | 2,871 | $ | 6,320 |
For
the Fiscal Quarters Ended
|
For
the Fiscal Year Ended
|
|||||||||||||||||||
In
thousands
|
July
31, 2008
|
October
31, 2008
|
January
31, 2009
|
April
30, 2009
|
April
30, 2009
|
|||||||||||||||
Sign
Making and Specialty Graphics:
|
||||||||||||||||||||
Gerber
Scientific Products
|
$ | 14,565 | $ | 18,954 | $ | 11,938 | $ | 12,003 | $ | 57,460 | ||||||||||
Spandex
|
69,111 | 62,581 | 45,430 | 49,665 | 226,787 | |||||||||||||||
Sign
Making and Specialty Graphics
|
83,676 | 81,535 | 57,368 | 61,668 | 284,247 | |||||||||||||||
Apparel
and Flexible Materials
|
48,949 | 45,382 | 36,437 | 32,197 | 162,965 | |||||||||||||||
Ophthalmic
Lens Processing
|
15,540 | 15,636 | 12,386 | 13,981 | 57,543 | |||||||||||||||
Consolidated
revenue
|
$ | 148,165 | $ | 142,553 | $ | 106,191 | $ | 107,846 | $ | 504,755 | ||||||||||
Sign
Making and Specialty Graphics:
|
||||||||||||||||||||
Gerber
Scientific Products
|
$ | (1,365 | ) | $ | 150 | $ | 334 | $ | (1,509 | ) | $ | (2,390 | ) | |||||||
Spandex
|
3,453 | 2,675 | 704 | 3,453 | 10,285 | |||||||||||||||
Sign
Making and Specialty Graphics
|
2,088 | 2,825 | 1,038 | 1,944 | 7,895 | |||||||||||||||
Apparel
and Flexible Materials
|
3,666 | 4,929 | 2,778 | 1,501 | 12,874 | |||||||||||||||
Ophthalmic
Lens Processing
|
115 | 1,773 | 737 | 573 | 3,198 | |||||||||||||||
Segment
operating income
|
5,869 | 9,527 | 4,553 | 4,018 | 23,967 | |||||||||||||||
Corporate
operating expenses
|
(4,321 | ) | (3,975 | ) | (4,336 | ) | (4,164 | ) | (16,796 | ) | ||||||||||
Consolidated operating
income
|
$ | 1,548 | $ | 5,552 | $ | 217 | $ | (146 | ) | $ | 7,171 |
GERBER
SCIENTIFIC, INC.
|
||
Date: December
15, 2009
|
By:
|
/s/ Michael R.
Elia
|
Michael
R. Elia
Executive Vice President and
Chief Financial Officer
(On behalf of the Registrant
and as
Duly Authorized
Officer)
|